Autopsy report · NCT01162382
Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging Study
Cause of deathStaffing, sites or logistics, also funding or business
“Grant support ended following which the key personnel (PI) left the institution.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 3 years 8 months before it stopped.
- 4 participants enrolled.
- Results were posted on the registry 5 years 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Washington University School of Medicine
- Sponsor type
- University, hospital or other
- Conditions
- Major Depressive Disorder
- Interventions
- Transcranial Magnetic Stimulation
- Participants
- 4
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
“Funding and PI leaving institution” - Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)
“PI left the institution” - Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
“The PI retired/left the institution. Efforts were made to contact the PI but were unsuccessful.” - Novel Gallium 68 Citrate in Orthopedic Infections
“PI left the institute and the funding expired.” - Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies
“Former PI Left the Institution”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.